BofA downgraded Olin to Neutral from Buy with a price target of $51, down from $62. An anticipated operating rate recovery is not materializing as expected and the slower-than-expected recovery is taking “a much bigger-than-expected toll on its earnings,” says the analyst, who lowered the firm’s chlorine/caustic soda price forecasts for 2025 and sees a more muted bounce-back in epoxies following soft market dynamics seen in Q2.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OLN:
